Quanterix gets FDA EUA status for Simoa SARS-CoV-2 N protein antigen test
Quanterix has secured an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its Simoa SARS-CoV-2 N protein antigen test. Simoa (single molecule array